The Asia Pacific urological device market will continue to expand through 2027 due to growing patient awareness of urological treatments in this region. In particular, rising use of minimally invasive laser treatments for urinary stones and BPH will drive sales in several segments of this market, thus fueling overall market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in Asia Pacific across a 10-year period.
- Urological Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): P Prasad, MS
Prasad Pallemsetty is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG